Olainfarm AS | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
77,956.30
93,654.00
97,392.00
110,693.00
122,076.00
124,256
Cost of Goods Sold (COGS) incl. D&A
40,749.60
31,682.00
35,096.00
43,759.00
50,403.00
52,441
Gross Income
37,206.70
61,972.00
62,296.00
66,934.00
71,673.00
71,815
SG&A Expense
21,806.90
43,792.00
45,187.00
54,359.00
58,514.00
58,522
EBIT
15,290.20
16,124.00
16,189.00
12,759.00
12,525.00
13,984
Unusual Expense
416.90
32.00
1.00
548.00
2,108.00
583
Non Operating Income/Expense
947.60
2,161.00
1,524.00
2,982.00
685.00
2,326
Interest Expense
231.90
492.00
448.00
612.00
694.00
642
Pretax Income
14,672.70
13,690.00
17,526.00
14,856.00
9,274.00
11,259
Income Tax
2,282.30
1,609.00
2,355.00
3,333.00
1,402.00
634
Equity in Affiliates
207.70
153.00
118.00
63.00
113.00
106
Consolidated Net Income
12,598.10
12,234.00
15,289.00
11,586.00
10,789.00
10,731
Net Income
12,729.00
12,237.00
15,281.00
11,579.00
10,789.00
10,731
Net Income After Extraordinaries
12,729.00
12,237.00
15,281.00
11,579.00
10,789.00
10,731
Net Income Available to Common
12,729.00
12,237.00
15,281.00
11,579.00
10,789.00
10,731
EPS (Basic)
0.91
0.87
1.08
0.82
0.77
0.76
Basic Shares Outstanding
14,085.10
14,085.10
14,085.10
14,085.10
14,085.10
14,085.10
EPS (Diluted)
0.90
0.87
1.08
0.82
0.77
0.76
Diluted Shares Outstanding
14,085.10
14,085.10
14,085.10
14,085.10
14,085.10
14,085.10
EBITDA
18,494.50
20,304.00
22,287.00
18,569.00
19,074.00
20,817
Other Operating Expense
109.60
2,056.00
920.00
184.00
634.00
691
Non-Operating Interest Income
145.10
187.00
262.00
275.00
236.00
76
Minority Interest Expense
130.90
3.00
8.00
7.00
-
-

About Olainfarm AS

View Profile
Address
5 Rupnicu iela
Olaine OL LV
Latvia
Employees -
Website http://www.olainfarm.lv
Updated 07/08/2019
Olainfarm AS is a pharmaceutical company, which engages in the manufacture and distribution of medicaments and chemical pharmaceutical products. It operates through the following segments: The medicine Production, Wholesale, Retail, Compression Materials, and Other. The Medicine Production segment engages in the production and sales of final form medicines and active pharmaceutical ingredients.